These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29241793)

  • 1. Hidradenitis suppurativa burden of disease tool: Pilot testing of a disease-specific quality of life questionnaire.
    Pinard J; Vleugels RA; Joyce C; Merola JF; Patel M
    J Am Acad Dermatol; 2018 Jan; 78(1):215-217.e2. PubMed ID: 29241793
    [No Abstract]   [Full Text] [Related]  

  • 2. Pain in Hidradenitis Suppurativa: A Pilot Study.
    Ring HC; Sørensen H; Miller IM; List EK; Saunte DM; Jemec GB
    Acta Derm Venereol; 2016 May; 96(4):554-6. PubMed ID: 26631388
    [No Abstract]   [Full Text] [Related]  

  • 3. Hidradenitis suppurativa: update on diagnosis and treatment. Introduction.
    Kerdel FA; Menter A; Micheletti RG
    Semin Cutan Med Surg; 2014 Jun; 33(3 Suppl):S47. PubMed ID: 25188456
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnosing Hidradenitis Suppurativa.
    Revuz JE; Jemec GB
    Dermatol Clin; 2016 Jan; 34(1):1-5. PubMed ID: 26617351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disutility in Patients with Hidradenitis Suppurativa: A Cross-sectional Study Using EuroQoL-5D.
    Riis PT; Vinding GR; Ring HC; Jemec GB
    Acta Derm Venereol; 2016 Feb; 96(2):222-6. PubMed ID: 25940640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interobserver variability of clinical scores in hidradenitis suppurativa is low.
    Sartorius K; Killasli H; Heilborn J; Jemec GB; Lapins J; Emtestam L
    Br J Dermatol; 2010 Jun; 162(6):1261-8. PubMed ID: 20184581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hidradenitis Suppurativa Area and Severity Index (HASI): a pilot study to develop a novel instrument to measure the physical signs of hidradenitis suppurativa.
    Goldfarb N; Ingram JR; Jemec GBE; Naik HB; Piguet V; Hyde MJ; Freese R; Lowes MA; Alavi A
    Br J Dermatol; 2020 Jan; 182(1):240-242. PubMed ID: 31286486
    [No Abstract]   [Full Text] [Related]  

  • 8. [Update of hidradenitis suppurativa in Primary Care].
    García-Martínez FJ; Pascual JC; López-Martín I; Pereyra-Rodríguez JJ; Martorell Calatayud A; Salgado-Boquete L; Labandeira-García J
    Semergen; 2017; 43(1):34-42. PubMed ID: 26874678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncovering burden disparity: A comparative analysis of the impact of moderate-to-severe psoriasis and hidradenitis suppurativa.
    Hamzavi IH; Sundaram M; Nicholson C; Zivkovic M; Parks-Miller A; Lee J; Yi J; Gu Y; Okun MM; Ganguli A; Arikian SR
    J Am Acad Dermatol; 2017 Dec; 77(6):1038-1046. PubMed ID: 28917381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hidradenitis Suppurativa: A Case Study.
    Schulman ML; Pantuso HM
    J Pediatr Health Care; 2015; 29(4):364-70. PubMed ID: 25575404
    [No Abstract]   [Full Text] [Related]  

  • 11. The Handicap of Hidradenitis Suppurativa.
    Deckers IE; Kimball AB
    Dermatol Clin; 2016 Jan; 34(1):17-22. PubMed ID: 26617353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open-label study of anakinra for the treatment of moderate to severe hidradenitis suppurativa.
    Leslie KS; Tripathi SV; Nguyen TV; Pauli M; Rosenblum MD
    J Am Acad Dermatol; 2014 Feb; 70(2):243-51. PubMed ID: 24314876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life impairment in hidradenitis suppurativa: a study of 61 cases.
    Wolkenstein P; Loundou A; Barrau K; Auquier P; Revuz J;
    J Am Acad Dermatol; 2007 Apr; 56(4):621-3. PubMed ID: 17097366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Living with hidradenitis suppurativa.
    Solarski ST
    Dermatol Nurs; 2004 Oct; 16(5):447-9. PubMed ID: 15624710
    [No Abstract]   [Full Text] [Related]  

  • 15. Quality of life in hidradenitis suppurativa: A cross-sectional study of a pediatric population.
    McAndrew R; Lopes FCPS; Sebastian K; Diaz LZ
    J Am Acad Dermatol; 2021 Mar; 84(3):829-830. PubMed ID: 33011326
    [No Abstract]   [Full Text] [Related]  

  • 16. Hidradenitis suppurativa: A growing concern.
    Jemec GB
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S3. PubMed ID: 26470612
    [No Abstract]   [Full Text] [Related]  

  • 17. Psychosocial impact of hidradenitis suppurativa: a qualitative study.
    Esmann S; Jemec GB
    Acta Derm Venereol; 2011 May; 91(3):328-32. PubMed ID: 21394419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing patients with hidradenitis suppurativa.
    Ball SL; Tidman MJ
    Practitioner; 2016 May; 260(1793):25-9, 3. PubMed ID: 27382916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiologic and clinical features of hidradenitis suppurativa.
    Parulkar I; Haleem H; Paek SY
    Semin Cutan Med Surg; 2017 Jun; 36(2):42-46. PubMed ID: 28538742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Questionnaire-based diagnosis of hidradenitis suppurativa: specificity, sensitivity and positive predictive value of specific diagnostic questions.
    Esmann S; Dufour DN; Jemec GB
    Br J Dermatol; 2010 Jul; 163(1):102-6. PubMed ID: 20331444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.